CalciMedica Statistics
Total Valuation
CalciMedica has a market cap or net worth of $43.07 million. The enterprise value is $31.83 million.
| Market Cap | 43.07M |
| Enterprise Value | 31.83M |
Important Dates
The last earnings date was Tuesday, August 29, 2023, after market close.
| Earnings Date | Aug 29, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
CalciMedica has 10.74 million shares outstanding. The number of shares has increased by 5,354.75% in one year.
| Shares Outstanding | 10.74M |
| Shares Change (YoY) | +5,354.75% |
| Shares Change (QoQ) | -20.84% |
| Owned by Insiders (%) | 14.87% |
| Owned by Institutions (%) | 53.08% |
| Float | 4.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.28 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.88, with zero debt.
| Current Ratio | 2.88 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -234.70% and return on invested capital (ROIC) is -466.78%.
| Return on Equity (ROE) | -234.70% |
| Return on Assets (ROA) | -165.70% |
| Return on Capital (ROIC) | -466.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.45M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.37% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | -3.37% |
| 50-Day Moving Average | 4.40 |
| 200-Day Moving Average | 3.62 |
| Relative Strength Index (RSI) | 41.07 |
| Average Volume (30 Days) | 23,358 |
Short Selling Information
The latest short interest is 37,173, so 0.35% of the outstanding shares have been sold short.
| Short Interest | 37,173 |
| Short Previous Month | 8,884 |
| Short % of Shares Out | 0.35% |
| Short % of Float | 0.82% |
| Short Ratio (days to cover) | 1.43 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -38.08M |
| Pretax Income | -34.36M |
| Net Income | -34.36M |
| EBITDA | -34.30M |
| EBIT | -34.36M |
| Earnings Per Share (EPS) | -$7.66 |
Balance Sheet
The company has $11.24 million in cash and no debt, giving a net cash position of $11.24 million or $1.05 per share.
| Cash & Cash Equivalents | 11.24M |
| Total Debt | n/a |
| Net Cash | 11.24M |
| Net Cash Per Share | $1.05 |
| Equity / Book Value | 8.16M |
| Book Value Per Share | 0.76 |
| Working Capital | 7.58M |
Cash Flow
In the last 12 months, operating cash flow was -$25.73 million and capital expenditures -$78,000, giving a free cash flow of -$25.81 million.
| Operating Cash Flow | -25.73M |
| Capital Expenditures | -78,000 |
| Free Cash Flow | -25.81M |
| FCF Per Share | -$5.75 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CalciMedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5,354.75% |
| Shareholder Yield | -5,354.75% |
| Earnings Yield | -79.77% |
| FCF Yield | -59.92% |
Analyst Forecast
The average price target for CalciMedica is $18.60, which is 363.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.60 |
| Price Target Difference | 363.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 20, 2023. It was a reverse split with a ratio of 1:14.
| Last Split Date | Mar 20, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:14 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |